Background. Access-related problems are one of the major causes of morbidity in elderly patients with chronic kidney disease. The aim of this study was to assess potential risks and benefits in elderly patients comparing forearm arteriovenous fistula (AVF) and perforating vein AVF below the elbow for primary vascular access. Methods. A retrospective comparison of elderly patients (65.7 6 9.3 years, 70.4% male patients, 36.2% late referral) undergoing primary vascular access surgery using forearm AVF (n ¼ 50) and perforating vein AVF (n ¼ 55) was performed over a 2-year period, including a multivariate analysis of potential risk factors and benefits of primary patency (PP ¼ intervention-free access survival) and secondary patency (SP ¼ access survival until abandonment). Results. Patency rates after 24 months were significantly higher in patients with perforating vein AVF (PP 1 SP: 78.2%) compared to forearm AVF (PP: 62%, SP: 56%, P ¼ 0.04). Presence of diabetes mellitus in patients with forearm AVF was associated with a decreased PP [odds ratio (OR): 3.6, 95% confidence interval (CI): 0.9-13.8] and SP (OR: 4.8, 95% CI: 1.3-17.9), and arterial hypertension was associated with a lower PP (OR: 6.7, 95% CI: 0.8-53.9), whereas the presence of hyperparathyroidism was associated with higher PP and SP (OR: 0.2, 95% CI: 0.1-0.7). In contrast, PP and SP in patients with perforating vein AVF were not influenced by comorbidities. Conclusions. Perforating vein AVF is superior to forearm AVF in elderly patients with diabetes and arterial hypertension due to the proximal fistula location, probably caused by an improved artery distensibility during fistula maturation.
Introduction
The forearm arteriovenous fistula (AVF) represents the first option for access creation in patients with chronic kidney disease (CKD) according to the updated kidney disease outcomes quality initiative (KDOQI) and European best practice guidelines [1, 2] . However, despite of the low incidence of thrombosis (0.2 events per patient per year) and infection (2%), the forearm AVF is burdened by a high early thrombosis and non-maturation rate ranging from 5 to 30%, which is mainly influenced by patient characteristics, such as age, diabetes mellitus and arteriosclerosis [3, 4] .
During the last three decades, characteristics of patients with CKD starting dialysis therapy have changed in terms of increasing age and comorbidities, e.g. diabetes mellitus, arterial hypertension, coronary heart disease and obesity [5] . In addition, damage of the venous vasculature is observed due to numerous blood samplings, infusions and intravenous lines during repeated hospitalizations [6] . These factors may contribute to the early failure rate of the forearm AVF, as a successful fistula maturation depends on both venous and artery dilatation and hence on the quality of arterial wall.
As arteriosclerosis is usually more pronounced distally, a more proximal fistula location at the proximal forearm, the elbow and upper arm region may be advantageous in elderly CKD patients suffering from diabetes and peripheral arterial disease [7] . However, although the incidence of thrombotic and infectious complications is low and longterm outcome is usually good, the major disadvantage of fistulas located at the elbow is the risk of high flow, which may lead to distal hypoperfusion and high-output cardiac failure especially in patients with coronary heart disease [8, 9] . A promising alternative in such patients would be the perforating vein AVF at the elbow, an arteriovenous (AV) anastomosis between the perforating vein and the brachial artery, originally described by Gracz and modified by Konner [10, 11, 12] . Using this technique, the anastomosis size to the brachial artery is defined by the diameter of the perforating vein (3-5 mm), thus avoiding high flow rates of the fistula. In addition, this technique does not change the natural topographic position of the perforating vein; the perforating vein is 'transposed' from the deep vein to an adjacent artery, mainly the brachial or the radial artery.
In view of the increasing incidence of elderly patients with diabetes and peripheral arterial disease, we postulated that the perforating vein AVF represents the more appropriate dialysis access rather than a forearm AVF. Comparing forearm and perforating vein AVF for primary vascular access, we report on the outcome and risk factors for access failure in these patients.
Materials and methods

Study design
This study is a single-centre retrospective evaluation of all patients exclusively undergoing construction of primary AV access for chronic haemodialysis comparing the forearm and perforating vein AVF at the elbow.
Patients and methods
Between February 2007 and August 2010, a total of 117 patients who consecutively underwent surgical placement of a primary AVF either by forearm or by perforating vein AVF entered this study. One surgeon (D.P.) performed all preoperative clinical examinations and all surgical procedures. The decision regarding type and location of the initial access was individually based on clinical and ultrasonographic findings, evaluating both the venous system and quality of the artery. A forearm AVF was only performed if the diameter of the radial and ulnar artery was !2.0 mm at the wrist level and no calcification or segmental stenosis was detected and the cephalic vein diameter at the wrist assessed using a tourniquet was !2.5 mm. Otherwise, a perforating vein AVF was performed provided that the perforating vein was detected by ultrasonography and the diameter of the brachial artery (>2.0 mm) and cephalic vein (>2.5 mm) was suitable. Surgery was preferentially performed in axillary brachial plexus anaesthesia or by local anaesthesia. No anticoagulants were routinely given in order to improve AVF patency after surgery.
Data collection
For all patients, reports on the first access creation including detailed anatomical drawings were available. Surgical access was defined as an establishment of an AVF access allowing for technically successful dialysis. In the case of late referrals, central venous dialysis catheters were preferentially inserted right-sided. Baseline data on the aetiology of renal failure, known cardiovascular and thromboembolic risk factors, demographics and concomitant medication were retrieved and recorded. Follow-up information was supplemented and verified through personal calls to all dialysis centres involved. Outcome parameters, patency and complication rates were calculated starting at the date of primary surgery until either renal transplantation or death. Factors that may influence access survival were studied with respect to primary patency (PP) and secondary patency (SP). Hyperparathyroidism was defined by the parathyroid hormone levels >300 pg/mL according to the reference values of the KDOQI [13] . PP (intervention-free access survival) was defined as the interval from time of access placement to any intervention designed to maintain or re-establish patency [14] . Secondary patency (access survival until abandonment) was defined as the interval from time of access placement to access abandonment or time of measurement of patency, including surgical or interventional procedures designed to re-establish the functionality of thrombosed accesses [14] . Primary failure was defined as an AVF that did not develop to maintain dialysis or thrombosed before the first successful cannulation for haemodialysis treatment. Secondary failure was defined as permanent failure of the AVF, after it had achieved adequacy for haemodialysis [15] .
Surgical technique
Forearm AVF (Brescia and Cimino) was created using the radial artery at the wrist and the cephalic vein was sutured in a side-to-side fashion using 7.0 non-absorbable monofil suturing material with subsequent ligation of the distal cephalic vein. By this, a functional side-to-end anastomosis between the radial artery and cephalic vein was created. The perforating vein AVF at the elbow was created using Konner's modification [6, 10] . In contrast to the Gracz approach, this modification preserves the deep venous system by not ligating the deep vein ( Figure 1 ).
Statistics
Statistical analyses were performed by SPSS 18.0 for Windows computer software (SPSS Inc., Chicago, IL). Chi-square testing to compare discrete variables and Student's t-test to compare continuous variables were applied as appropriate. Univariate analysis of PP and SP of the first AV access was carried out using the Kaplan-Meier method, with date of fistula failure as uncensored end point. Patency calculations were monitored for death, renal transplantation or termination of haemodialysis access. Multivariable logistic regression analysis was used to evaluate the association between PP, SP and risk factors. A P-value of <0.05 was considered to indicate statistical significance. All data are presented as absolute numbers, range or mean and SEM. Estimated relative risks odds ratio (OR) and their 95% confidence intervals (CI) are reported for all variables.
Results
During the observation period, five patients died with a functioning AVF and six patients underwent successful renal transplantation. In one patient, the use of the vascular access was terminated due to the recovery of renal function. These patients (n ¼ 12) were excluded from the following analysis.
Demographics
Demographic data of the study population are given in Table 1 and aetiology of renal insufficiency are given in Table 2 . Mean age of the study population was 65.7 AE 9.3 years, which did not differ significantly between the study groups. In both groups, more than two-thirds of all patients were male. Late referral was observed in more patients receiving a forearm AVF (46%) than in patients receiving a perforating vein AVF (27.3%) for primary vascular access. Among the factors that might have influenced access survival, type 2 diabetes was observed in 60% of all patients receiving a forearm AVF and 45.5% of patients receiving a perforating vein AVF. The proportion of patients with arterial hypertension and hyperparathyroidism was comparable in both groups.
Comparison of forearm and perforating vein AVF
Three-, 6-, 12-, 18-and 24-month patency rates are shown in Figure 2 . Patency rates after 24 months were significantly higher in patients with perforating vein AVF (PP 1 SP: 78.2%) compared to forearm AVF (PP: 62%, SP: 56%, P ¼ 0.04). During surgery, more than half of all patients in both groups had arteriosclerotic changes of the radial or brachial artery, e.g. plaques or segmental wall thickening. These arteriosclerotic changes were more frequently seen in patients with diabetes and/or arterial hypertension. The thrombosis rates varied by access types showing the lowest rate in the perforating vein AVF group. Early thrombosis within the first 3 months occurred significantly more frequently in patients with forearm AVF (3 months PP: 78% versus 91%, P ¼ 0.01). The number of redo procedures in order to maintain functioning access over time did not differ significantly between both groups (perforating vein AVF: 11/55 ¼ 20% versus forearm AVF: 8/50 ¼ 16%). Distal hypoperfusion of the hand (1°steal phenomena) occurred in three patients with perforating vein AVF (5.4%) and two patients with forearm AVF (4%) and was conservatively treated.
Patency rates stratified for risk factors All patients. In 19 patients (18.1%), one or more redo procedures were necessary to maintain functioning access over time. Kaplan-Meier life table analysis revealed an overall mean PP of 28.1 AE 1.6 and mean SP of 29.5 AE 1.6 months (P ¼ 0.98). Diabetes and arterial hypertension were risk factors, which led to a significant shorter primary and secondary patency rate in all patients (Table 3) . In contrast, patients with hyperparathyroidism showed a significant prolonged PP and SP rate. No gender-specific differences regarding the patency rate have been detected in this study. Multivariate analysis was performed on all 105 patients in the study to identify independent factors that were associated with the patency rate. Three factors were examined, including diabetes, arterial hypertension and hyperparathyroidism. On multivariate analysis, hyperparathyroidism was an independent factor that was significantly associated with an increased PP and SP (OR: 0.29; 95% CI: 0.13-0.67, Table 4 ) in all patients, whereas arterial hypertension was an independent risk factor that was significantly associated with AVF failure in this study (OR for SP: 3.4; 95% CI: 1.1-9.9, Table 4 ). Forearm AVF. In eight patients who have received a forearm AVF (16%), one or more redo procedures were necessary to maintain functioning access over time. The mean secondary patency rate did not differ significantly from the PP rate (24.5 AE 2.7 versus 25.9 AE 2.6 months, P ¼ 0.976). Diabetes and arterial hypertension were risk factors, which significantly shortened the PP and SP rate of patients with forearm AVF. Patients with concomitant hyperparathyroidism had a significantly increased PP and SP rate (Table 5) . Patency rates after forearm AVF were not influenced by gender-specific factors. Multivariate analysis was performed on all 50 patients with forearm AVF in the study to identify independent factors that were associated with the patency rate. Three factors were examined, including diabetes, arterial hypertension and hyperparathyroidism. On multivariate analysis, hyperparathyroidism was an independent factor that was significantly associated with an increased PP [OR: 0.23; 95% CI: 0.07-0.74 (Table 6 )] and SP [OR: 0.23; 95% CI: 0.07-0.7 (Table 6) ]. In contrast, diabetes represented an independent risk factor that was associated with a decreased PP and SP rate [OR for SP: 4.8; 95% CI: 1.3-17.9 (Table 6) ]. However, arterial hypertension represented an independent risk factor for PP but not for SP rate in patients with forearm AVF.
Perforating vein AVF.
Eleven patients who received a perforating vein AVF (20%) needed one or more redo procedures to maintain functioning access over time. PP and SP rate did not differ significantly. In the univariate and multivariate analyses, PP and SP in the perforating vein AVF group were not influenced by the presence of diabetes, arterial hypertension, hyperparathyroidism or gender-specific factors (Table 7) . 
Discussion
Access-related problems remain as one of the major causes of morbidity in elderly patients with CKD [16] . A recent meta-analysis of dialysis access outcome in elderly patients found an increased risk of forearm fistula failure and significant benefit of proximal brachiocephalic fistulas [17] . The perforating vein AVF is considered as a valid alternative to the brachiocephalic AVF, showing similar patency but avoiding high flow rates of the fistula [11, 12] . In this study for the first time, forearm and perforating vein AVF for primary vascular access were compared in elderly patients showing excellent patency rates for perforating vein AVF in contrast to forearm AVF depending on various patient variables. Elderly CKD patients starting maintenance haemodialysis therapy often suffer from diabetes and arterial hypertension. In particular, the combination of age and diabetes impairs fistula outcome with significantly higher failure rates up to 42% [2] . In these patients, peripheral arterial disease with thickened or even calcified arteries might have impaired fistula maturation [18, 19] . AVF maturation also depends on the availability of a suitable vein and likewise on the ability of the artery to dilate, the distensibility of the arterial wall being an additional factor [20] . Since, during the primary fistula creation, more vessel calcifications were detected in diabetics and hypertensive patients, a more proximal fistula location has proven successful for PP rate and fistula maturation [21, 22] . In this study, almost half of all patients suffered from diabetes and two-thirds from arterial hypertension which were distinguished as independent risk factors associated with a decreased patency rate. During vascular access creation, these comorbidities were commonly accompanied with arteriosclerosis and thickening of the arterial wall in both forearm and perforating vein AVF. The significant higher patency rate in diabetic patients with perforating vein AVF in comparison to forearm AVF in this study can be explained by the more proximal location of the fistula. The major artery diameter of the brachial artery seems to ensure a sufficient arterial inflow for fistula patency and maturation even in the case of a restricted distensibility and compliance of the arterial wall in these patients. Due to the inflow control of the perforating vein AVF using Konner's modification, no hyperdynamic fistulas were observed by the clinical examination in this study corresponding to the study of Chin et al. [22] showing blood flow regulation in perforating vein AVF by ultrasound velocity dilution during haemodialysis. However, limitations of this study exist since the results reflect the performance of a single centre and a single surgeon and thus may not be generalized to surgeons who are less experienced in this technique. Gender differences had no impact on AV patency in elderly patients in this and other studies [3] . The oftendescribed smaller diameter of arteries and veins in women does not have any impact on fistula patency and maturation. As demonstrated by successful AVF creation in children, the initial diameter is less important when an adequate inflow and arterial wall distensibility exists [6] .
Late referral of patients starting dialysis treatment with a temporary central venous catheter can impair the patency rate and fistula maturation. Catheter complications can lead to a premature fistula cannulation with consecutive AVF failure due to haematoma formation, fibrosis and vessel wall damage [23] [24] [25] . In this study, late referral was observed in almost one-third of all patients who simultaneously received a tunnelled cuffed catheter. Late referral did not have any impact on patency rate and fistula maturation in this study because in accordance with the KDOQI guidelines, we usually allow AVF to mature for at least 6 weeks before cannulation [1] .
Interestingly, hyperparathyroidism observed in about half of all patients in this study was associated with significantly higher patency rates especially after forearm AVF and represented an independent protective factor associated with fistula patency in the multivariate analysis. However, in contrast to our results and another recently published study [26] , other studies describe hyperparathyroidism as an independent risk factor for vascular access thrombosis, probably induced by microcalcification of the vessel wall [27, 28] . Further investigations are necessary to clarify a potential relationship between hyperparathyroidism and vascular access patency.
In conclusion, the perforating vein AVF is superior to forearm AVF in elderly patients with diabetes and arterial hypertension due to the proximal fistula location, probably caused by an improved artery distensibility and an initially high blood inflow during fistula maturation. However, paying particular attention to the preservation of the venous capital, forearm AVF should still be considered in elderly patients without diabetes or severe arteriosclerosis. The beneficial effect of hyperparathyroidism on fistula patency and maturation warrants more extensive investigations aiming at the interrelationship between parathormone and neoangiogenesis.
